Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...

Pancreatic cancer is one of the deadliest malignancies, with survival rates remaining dismally low despite major advances in ...

A molecule involved in red blood cell production determines whether the immune system attacks or ignores cells in the body via peripheral immune tolerance, Stanford Medicine-led research finds.

The bacterium that causes TB can hide in liver cells called hepatocytes, and reprogram their metabolism for its own benefit.

Emerging research highlights the profound influence of the brain–gut axis and neuroendocrine signaling pathways in the development, progression, and ...

The firm's Phase I/II study yielded responses in mCRPC patients with androgen receptor mutations but it wasn't as promising in HR-positive breast cancer.